Pharmaceutical group · United States
Mallinckrodt
A group of 14 companies with 82 medicines in 4 countries.
Group structure
14 companies in 4 countries
Loading your page…
Loading your page…
Pharmaceutical group · United States
A group of 14 companies with 82 medicines in 4 countries.
14 companies in 4 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 82
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACTHAR GEL40 units/ml | 80 units/ml · Injectable | Corticotropin | United States | Marketed | 1952 |
| ACTHAR GEL (AUTOINJECTOR)40 units/0.5ml | 80 units/ml · Injectable | Corticotropin | United States | Marketed | 1952 |
| ANEXSIA500mg; 5mg | 750mg; 10mg · Tablet | Paracetamol, Hydrocodone | United States | Not marketed | 1987 |
| ANEXSIA 7.5/650650mg; 7.5mg · Tablet | Paracetamol, Hydrocodone | United States | Not marketed | 1987 |
| ANGIO-CONRAY80% · Injectable | Iotalamic acid | United States | Not marketed | 1996 |
| BAROS460mg/gm; 420mg/gm · Granule, effervescent | Bicarbonate, Tartaric acid | United States | Not marketed | 1985 |
| BUCET650mg; 50mg · Capsule | Paracetamol, Butalbital | United States | Not marketed | 1985 |
| CHOLEBRINE750mg · Tablet | Iocetamic acid | United States | Not marketed | 1973 |
| CONRAY 32554.3% · Injectable | Iotalamic acid | United States | Not marketed | 1976 |
| CONRAY 40066.8% · Injectable | Iotalamic acid | United States | Not marketed | 1963 |
| FEMCET325mg; 50mg; 40mg · Capsule | Paracetamol, Butalbital, Caffeine | United States | Not marketed | |
| FERROUS CITRATE FE 5959 25uCi/ML · Injectable | Ferrous, Fe-59 | United States | Not marketed | 1973 |
| HIPPURAN I 131131 0.25mCi/ML · Injectable | Iodohippurate i-131 | United States | Not marketed | 1968 |
| HYDROCODONE BITARTRATE AND ACETAMINOPHEN500mg; 5mg · Capsule | Paracetamol, Hydrocodone | United States | Not marketed | 1985 |
| INOMAX100PPM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 4880PPM | 800PPM · GAS | Nitric oxide | United States | Marketed | 1999 |
| LORCET-HD500mg; 5mg · Capsule | Paracetamol, Hydrocodone | United States | Not marketed | 1982 |
| MD-5050% · Injectable | Diatrizoate | United States | Not marketed | |
| MD-6052%; 8% · Injectable | Diatrizoate | United States | Not marketed | |
| MD-7666%; 10% · Injectable | Diatrizoate | United States | Not marketed | |
| METHADONE HYDROCHLORIDE100gm/bot | 500gm/bot | 50gm/bot · Powder | Methadone | United States | Not marketed | 1947 |
| METHADOSE10 mg / ml · Solution | Methadone | Canada | Marketed | 2013 |
| METHADOSE10 mg / ml · Solution | Methadone | Canada | Marketed | 2013 |
| OFIRMEV1GM/100ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Paracetamol | United States | Not marketed | 2010 |
| OSTEOSCAN99m etidronate kit n/a · Injectable | Technetium tc-99m etidronate kit n/a | United States | Not marketed | 1973 |
| PERCHLORACAP200mg · Capsule | Perchlorate | United States | Not marketed | 1974 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 38 | 35 | 3 | CompaniesAll medicines |
| Canada | 34 | 2 | 32 | CompaniesAll medicines |
| Spain | 8 | 0 | 8 | CompaniesAll medicines |
| European Union (EMA) | 2 | 0 | 2 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.